Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE:300760)
236.49
+2.19 (0.93%)
Aug 13, 2025, 3:04 PM CST
Ligand Pharmaceuticals Market Cap
SHE:300760 has a market cap or net worth of 283.36 billion as of August 13, 2025. Its market cap has decreased by -15.57% in one year.
Market Cap
283.36B
Enterprise Value
270.92B
Revenue
35.59B
Ranking
n/a
PE Ratio
25.48
Stock Price
$236.49
Market Cap Chart
Since October 16, 2018, SHE:300760's market cap has increased from 85.43B to 283.36B, an increase of 231.70%. That is a compound annual growth rate of 19.21%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 11, 2025 | 278.77B | -9.61% |
Dec 31, 2024 | 308.40B | -12.25% |
Dec 29, 2023 | 351.45B | -8.03% |
Dec 30, 2022 | 382.13B | -17.25% |
Dec 31, 2021 | 461.77B | -10.83% |
Dec 31, 2020 | 517.88B | 134.19% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Oct 16, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 407.67B |
WuXi AppTec | 267.30B |
Zhangzhou Pientzehuang Pharmaceutical., | 122.37B |
Sichuan Biokin Pharmaceutical | 121.66B |
Aier Eye Hospital Group | 120.66B |
Shanghai United Imaging Healthcare | 107.16B |
Yunnan Baiyao Group Co.,Ltd | 99.94B |
Huadong Medicine | 74.46B |